ZYVERSA THERAPEUTICS, INC. Preferred Stock, Value, Issued
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Preferred Stock, Value, Issued of $1 as of 2023-12-31, per its 10-K filed 2024-03-25.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:PreferredStockValue · last filed 2024-03-25
- 2023-12-31: Preferred Stock, Value, Issued $1.00.
- 2022-12-31: Preferred Stock, Value, Issued $1.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2023-12-31 | $1.00 10-K · filed 2024-03-25 |
| 2022-12-31 | $1.00 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |